FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Julie Johnson

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
Christophe Nicot; Miroslav Dundr; Julie M Johnson; Jake R Fullen; Norma Alonzo; Risaku Fukumoto; Gerald Princler; David Derse; Tom Misteli; Genoveffa Franchini
HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.
Genoveffa Franchini; Christophe Nicot; Julie M Johnson
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
Zdenek Hel; Elzbieta Tryniszewska; Wen-Po Tsai; Julie M Johnson; Robert Harrod; Jake R Fullen; Vaniambadi S Kalyanaraman; John D Altman; James McNally; Tatiana S Karpova; Barbara K Felber; Jim Tartaglia; Genoveffa Franchini
Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Julie Johnson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Christophe Nicot; Miroslav Dundr; Julie M Johnson; Jake R Fullen; Norma Alonzo; Risaku Fukumoto; Gerald Princler; David Derse; Tom Misteli; Genoveffa Franchini
HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.
Nature medicine 2004;10(2):197-201.
2003: Genoveffa Franchini; Christophe Nicot; Julie M Johnson
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
Advances in cancer research 2003;89():69-132.
2002: Zdenek Hel; Elzbieta Tryniszewska; Wen-Po Tsai; Julie M Johnson; Robert Harrod; Jake R Fullen; Vaniambadi S Kalyanaraman; John D Altman; James McNally; Tatiana S Karpova; Barbara K Felber; Jim Tartaglia; Genoveffa Franchini
Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes.
DNA and cell biology 2002;21(9):619-26.
2002: Julie M Johnson; Genoveffa Franchini
Retroviral proteins that target the major histocompatibility complex class I.
Virus research 2002;88(1-2):119-27.
2002: Zdenek Hel; Julie M Johnson; Elzbieta Tryniszewska; Wen-Po Tsai; Robert Harrod; Jake R Fullen; Jim Tartaglia; Genoveffa Franchini
A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.
Vaccine 2002;20(25-26):3171-86.
2001: Christophe Nicot; JC Mulloy; Maria Grazia Ferrari; Julie M Johnson; K Fu; Risaku Fukumoto; R Trovato; Jake R Fullen; Warren J Leonard; Genoveffa Franchini
HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells.
Blood 2001;98(3):823-9.
2001: Julie M Johnson; Christophe Nicot; Jake R Fullen; Vincenzo Ciminale; L Casareto; JC Mulloy; S Jacobson; Genoveffa Franchini
Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.
Journal of virology 2001;75(13):6086-94.
2001: Julie M Johnson; Robert Harrod; Genoveffa Franchini
Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).
International journal of experimental pathology 2001;82(3):135-47.
2000: Julie M Johnson; JC Mulloy; Vincenzo Ciminale; Jake R Fullen; Christophe Nicot; Genoveffa Franchini
The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2.
AIDS research and human retroviruses 2000;16(16):1777-81.
2000: Gregory A Dekaban; AA Peters; JC Mulloy; Julie M Johnson; R Trovato; ED Rivadeneira; Genoveffa Franchini
The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.
Virology 2000;274(1):86-93.
1999: R Trovato; JC Mulloy; Julie M Johnson; Shigeki Takemoto; M P de Oliveira; Genoveffa Franchini
A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stability.
Journal of virology 1999;73(8):6460-7.